Speciality Medicines finalizes commercial arrangement to market product
The arrangement is expected to significantly enhance the Company’s distribution network and revenue visibility
Speciality Medicines has finalized a commercial arrangement with an international entity specializes in importing and distributing the Pharmaceutical Finished Products, supporting its future growth. Under the said deal, the said entity has agreed to distribute, market and sell the Products of the company of value of $1.5 million (an approximate value of Rs 14 crore), subject to terms and conditions as mutually agreed.
The arrangement is expected to significantly enhance the Company’s distribution network and revenue visibility.
Speciality Medicines is primarily engaged in the business of marketing and distribution of finished formulations of specialty pharmaceutical products, comprising of high-cost oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases.
